| Literature DB >> 33341152 |
Y Y Lee1, D Chisholm2, M Eddleston3, D Gunnell4, A Fleischmann5, F Konradsen6, M Y Bertram7, C Mihalopoulos8, R Brown9, D F Santomauro10, J Schess11, M van Ommeren5.
Abstract
BACKGROUND: Reducing suicides is a key Sustainable Development Goal target for improving global health. Highly hazardous pesticides are among the leading causes of death by suicide in low-income and middle-income countries. National bans of acutely toxic highly hazardous pesticides have led to substantial reductions in pesticide-attributable suicides across several countries. This study evaluated the cost-effectiveness of implementing national bans of highly hazardous pesticides to reduce the burden of pesticide suicides.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33341152 PMCID: PMC7886657 DOI: 10.1016/S2214-109X(20)30493-9
Source DB: PubMed Journal: Lancet Glob Health ISSN: 2214-109X Impact factor: 38.927
Figure 1Overall suicide rate in Sri Lanka, 1880–2015
Arrows show timing of pesticide bans in 1984 (parathion and methylparathion), 1995 (all remaining WHO class 1 toxicity pesticides, including methamidophos and monocrotophos), 1998 (endosulfan), and 2008 (dimethoate, fenthion, and paraquat). Suicide data were obtained from police records. Reproduced with permission from Knipe et al.
Overall suicide rates and the proportion of suicides attributable to pesticide self-poisoning across 20 countries
| Bangladesh | Males: 5·88; females: 6·02 | Both: 20·9% (range 10·5–31·4) | 2014 country-specific estimate from Chowdhury et al; |
| Ethiopia | Males: 7·34; females: 2·54 | Both: 24·0% (range 12·0–36·0) | AFRO regional estimate; |
| Guatemala | Males: 9·21; females: 2·32 | Males: 16·8% (n=352); females: 27·1% (n=144) | 2015 estimate from WHO mortality database |
| India | Males: 16·97; females: 13·49 | Males: 34·0% (range 23·8–44·2); females: 29·0% (range 20·3–37·7) | Adjusted |
| Indonesia | Males: 4·63; females: 1·47 | Both: 11·3% (range 5·7–17·0) | SEARO regional estimate; |
| Nigeria | Males: 5·40; females: 2·53 | Both: 24·0% (range 12·0–36·0) | AFRO regional estimate; |
| Pakistan | Males: 3·97; females: 4·53 | Both: 7·1% (range 3·6–10·7) | EMRO regional estimate; |
| Philippines | Males: 8·16; females: 2·53 | Males: 3·4% (n=1411); females: 4·4% (n=409) | 2008 estimate from WHO mortality database |
| Ukraine (out of scope) | Males: 56·66; females: 8·38 | Both: 0·9% (range 0·5–1·4) | EURO regional estimate; |
| Vietnam | Males: 10·67; females: 4·90 | Both: 11·3% (range 5·7–17·0) | SEARO regional estimate; |
| China | Males: 10·67; females: 7·47 | Both: 49·0% (n=120 730) | 2013 country-specific estimate from Page et al |
| Germany (out of scope) | Males: 22·06; females: 7·49 | Males: 0·2% (n=7397); females: 0·1% (n=2681) | 2015 estimate from WHO mortality database |
| Iran | Males: 8·29; females: 3·25 | Males: 5·8%; (n=1669); females: 7·1% (n=706) | 2015 estimate from WHO mortality database |
| Japan (out of scope) | Males: 31·87; females: 13·50 | Males: 0·8% (n=16 202); females: 1·4% (n=6950) | 2015 estimate from WHO mortality database |
| Mexico | Males: 10·10; females: 2·13 | Males: 3·0% (n=5031); females: 7·0% (n=1251) | 2015 estimate from WHO mortality database. |
| Russia (out of scope) | Males: 52·88; females: 10·18 | Both: 1·7% (range 0·9–2·6) | HIC regional estimate. |
| South Africa | Males: 18·35; females: 4·59 | Males: 2·9% (n=377); females: 6·7% (n=105) | 2015 estimate from WHO mortality database |
| Thailand | Males: 20·15; females: 5·02 | Males: 15·5% (n=3283); females: 22·4% (n=848) | 2016 estimate from WHO mortality database |
| Turkey (out of scope) | Males: 5·67; females: 1·43 | Males: 0·1% (n=1135); females: 0·8% (n=397) | 2015 estimate from WHO mortality database |
| USA (out of scope) | Males: 23·61; females: 6·70 | Males: 0·0% (n=33 959); females: 0·1% (n=10 186) | 2015 estimate from WHO mortality database |
LLMICs=low-income and lower-middle-income countries. AFRO=African region. SEARO=southeast Asian region. EMRO=eastern Mediterranean region. EURO=European region. UMHICs=upper-middle-income and high-income countries. HIC=high-income country.
In the uncertainty analysis, proportions with uncertainty ranges denoted by range were modelled using the PERT distribution, with arguments comprising the minimum, most likely, and maximum values. Conversely, proportions with uncertainty ranges denoted by N were modelled using the beta distribution (ie, the conjugate prior of the binomial distribution).
AFRO regional estimates were from the 2007 systematic review by Gunnell et al instead of the 2017 systematic review by Mew et al. The 2017 AFRO regional estimate was likely to be a significant underestimate given that data were only available for South Africa and Mauritius, which were not representative of the broader AFRO region. The previous 2007 AFRO regional estimate was estimated to be between 15% and 33%, the average of which was used for the current study.
The original study was based on data from a 2001–03 survey that estimated the proportion of suicides due to pesticides in India was 39% among males and 35% among females. These estimates were adjusted downwards based on the expert opinion of two study authors (ME and DG) to account for declining trends in the proportion of suicides due to pesticides, which have been observed in national police report data (ie, the Government of India National Crime Records Bureau).
Six out-of-scope countries were excluded from the economic evaluation because they involved a proportion of suicides due to pesticide self-poisoning that was less than 2% (ie, the threshold below which it would not be worthwhile to implement a national ban of highly hazardous pesticides).
Figure 2Overview of the demographic projection model
Population-standardised results for the base case analysis
| LLMICs (n=9) | 2476 | $94 (73–123) | $7675 (6931–8389) | 81·77 (63·29–101·99) |
| UMHICs (n=5) | 1762 | $237 (191–303) | $6008 (5237–6709) | 25·33 (20·20–30·97) |
| 2–9% (n=5) | 571 | $699 (515–940) | $10 769 (9787–11 776) | 15·42 (11·65–20·87) |
| 10–19% (n=3) | 429 | $598 (449–796) | $8383 (7439–9363) | 14·02 (10·59–17·68) |
| 20–29% (n=4) | 471 | $213 (168–281) | $8224 (7318–9059) | 38·66 (29·33–47·73) |
| >30% (n=2) | 2767 | $75 (58–99) | $5762 (5012–6550) | 77·07 (60·43–97·86) |
Data are n (95% uncertainty interval). Costs are in 2017 I$. I$=international dollars. HLYG=healthy life-years gained. LLMICs=low-income and lower-middle-income countries. UMHICs=upper-middle-income and high-income countries.
Figure 3Tornado graphs for the univariate deterministic sensitivity analysis for LLMICs (A) and UMHICs (B)
LLMICs=low-income and lower-middle-income countries. UMHICs=upper-middle-income and high-income countries.
Cost-effectiveness ratios from sensitivity analysis applying different discount rates to health effects and intervention costs
| LLMICs (n=9) | $94 (73–123) | $179 (139–233) | $280 (218–376) | $108 (84–139) | $83 (64–113) |
| UMHICs (n=5) | $237 (191–303) | $339 (270–432) | $456 (365–596) | $271 (215–337) | $211 (167–273) |
| 2–9% (n=5) | $699 (515–940) | $1650 (1198–2219) | $2934 (2074–3910) | $799 (582–1079) | $614 (441–823) |
| 10–19% (n=3) | $598 (449–796) | $995 (761–1327) | $1480 (1109–1981) | $685 (506–892) | $529 (398–696) |
| 20–29% (n=4) | $213 (168–281) | $496 (392–652) | $886 (696–1160) | $244 (192–321) | $189 (148–247) |
| >30% (n=2) | $75 (58–99) | $131 (102–174) | $197 (154–259) | $86 (66–113) | $67 (52–88) |
Data are n (95% uncertainty interval). Costs are in 2017 I$. I$=international dollars. HLYG=healthy life-years gained. LLMICs=low-income and lower-middle-income countries. UMHICs=upper-middle-income and high-income countries.
The baseline scenario applied a discount rate of 0% to health effects and 3% to intervention costs.